USB
51
4
HOG
47
4
AMAT
42
2
MSI
55
8
ITW
37
4
MET
74
2
ILMN
27
2
QRVO
23
13
RF
67
4
PFE
30
-17
WYNN
36
4
LEG
31
2
WFC
77
3
EQIX
57
4
WHR
50
3
VMC
68
3
ES
24
-2
CME
59
-2
AMG
63
2
SE
71
3
USB
51
4
HOG
47
4
AMAT
42
2
MSI
55
8
ITW
37
4
MET
74
2
ILMN
27
2
QRVO
23
13
RF
67
4
PFE
30
-17
WYNN
36
4
LEG
31
2
WFC
77
3
EQIX
57
4
WHR
50
3
VMC
68
3
ES
24
-2
CME
59
-2
AMG
63
2
SE
71
3
Financhill
Back

Citizens Financial Services Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
43

CZFS
Citizens Financial Services

Last Price:
$58.10
Seasonality Move:
1.37%
Buy
60

ALNY
Alnylam Pharmaceuticals

Last Price:
$280.77
Seasonality Move:
3.3%
Sell
43
Citizens Financial Services (CZFS) is a Sell

Is Citizens Financial Services a Buy, Sell or Hold?

  • The current Citizens Financial Services [CZFS] share price is $58.09. The Score for CZFS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CZFS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CZFS Stock Price Chart

What is Citizens Financial Services's stock price today?

  • The Citizens Financial Services share price today is $58.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CZFS is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $290.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

CZFS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.94 Buy
Relative Strength Index (14 RSI): 46.57 Sell
Chaikin Money Flow: -4836 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.12 - 61.74) Sell
Bollinger Bands (100): (58.67 - 68.47) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.72 Buy
Relative Strength Index (14 RSI): 71.41 Buy
Chaikin Money Flow: -979016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.44 - 263) Buy
Bollinger Bands (100): (240.32 - 271.8) Buy

CZFS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 58.09 Buy
20-day SMA: 58.62 Sell
50-day SMA: 60.37 Sell
200-day SMA: 56.87 Buy
8-day EMA: 30.83 Buy
20-day EMA: 15.12 Buy
50-day EMA: 6.6 Buy
200-day EMA: 1.72 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 257.74 Buy
20-day SMA: 249.75 Buy
50-day SMA: 257.54 Buy
200-day SMA: 251.5 Buy
8-day EMA: 263.89 Buy
20-day EMA: 256.08 Buy
50-day EMA: 255.39 Buy
200-day EMA: 243.44 Buy

Citizens Financial Services Earnings Growth & CZFS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.03 per share, an increase this year of $1.09 per share, and an increase next year of $0.35 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Citizens Financial Services Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):